Neutral lineage tracing of proliferative embryonic and adult mammary stem/progenitor cells by Lloyd-Lewis, Bethan et al.
                          Lloyd-Lewis, B., Davis, F. M., Harris, O. B., Hitchcock, J. R., & Watson, C.
J. (2018). Neutral lineage tracing of proliferative embryonic and adult
mammary stem/progenitor cells. Development (Cambridge), 145,
[dev164079]. https://doi.org/10.1242/dev.164079
Publisher's PDF, also known as Version of record
License (if available):
CC BY
Link to published version (if available):
10.1242/dev.164079
Link to publication record in Explore Bristol Research
PDF-document
This is the final published version of the article (version of record). It first appeared online via Company of
Biologists at https://dev.biologists.org/content/145/14/dev164079. Please refer to any applicable terms of use of
the publisher.
University of Bristol - Explore Bristol Research
General rights
This document is made available in accordance with publisher policies. Please cite only the published
version using the reference above. Full terms of use are available:
http://www.bristol.ac.uk/pure/about/ebr-terms
STEM CELLS AND REGENERATION RESEARCH REPORT
Neutral lineage tracing of proliferative embryonic and adult
mammary stem/progenitor cells
Bethan Lloyd-Lewis1,*,§,¶, Felicity M. Davis1,‡,§,¶, Olivia B. Harris1,2, Jessica R. Hitchcock1 and
Christine J. Watson1,2,¶
ABSTRACT
Mammary gland development occurs over multiple phases, beginning
in themammalian embryo and continuing throughout reproductive life.
The remarkable morphogenetic capacity of the mammary gland at
each stage of development is attributed to the activities of distinct
populations of mammary stem cells (MaSCs) and progenitor cells.
However, the relationship between embryonic and adult MaSCs, and
their fate during different waves of mammary gland morphogenesis,
remains unclear. By employing a neutral, low-density genetic labelling
strategy, we characterised the contribution of proliferative stem/
progenitor cells to embryonic, pubertal and reproductive mammary
gland development. Our findings further support a model of lineage
restriction of MaSCs in the postnatal mammary gland, and highlight
extensive redundancy and heterogeneity within the adult stem/
progenitor cell pool. Furthermore, our data suggest extensive
multiplicity in their foetal precursors that give rise to the primordial
mammary epithelium before birth. In addition, using a single-cell
labelling approach, we revealed the extraordinary capacity of a single
embryonic MaSC to contribute to postnatal ductal development.
Together, these findings provide tantalising new insights into the
disparate and stage-specific contribution of distinct stem/progenitor
cells to mammary gland development.
KEY WORDS: Mammary gland development, Embryonic mammary
stem cells, Adult mammary stem cells, Lineage tracing
INTRODUCTION
Mammary gland development is a complex and multi-stage process
that begins in the embryo and continues throughout the reproductive
life of female mammals (Cowin and Wysolmerski, 2010; Gjorevski
and Nelson, 2011; Hinck and Silberstein, 2005). This process
commences with the formation of two milk lines from the overlying
ectoderm on embryonic day (E) 10.5 in mice, and the asynchronous
appearance of five pairs of placodes at specific and symmetric
locations between the fore- and hindlimbs by E11.5 (Hens and
Wysolmerski, 2005). These ectodermal placodes develop
asynchronously and invaginate to form the mammary bud by
E13.5, followed by the formation of an epithelial tubular sprout by
E15.5-16.5 that invades the underlying mammary fat pad precursor.
Contact with the developing fat pad initiates a phase of branching
morphogenesis, resulting in the formation of the primordial ductal
tree by E18.5, prior to birth (Veltmaat, 2017; Veltmaat et al., 2003;
Watson and Khaled, 2008).
In the weeks immediately after birth, growth of the ductal tree is
commensurate with body growth and it is not until puberty that
ductal structures begin to elongate rapidly and invade the empty fat
pad, driven by hormonal and growth factor signalling in the micro-
environment (Hinck and Silberstein, 2005). This process, known as
ductal morphogenesis, is orchestrated by proliferation of adult
mammary stem and progenitor cells within the distal terminal end
bud (TEB) structures (Bai and Rohrschneider, 2010; Paine et al.,
2016; Sreekumar et al., 2015). After pubertal growth is complete,
the mammary epithelium re-enters a phase of balanced proliferation,
with only minor growth and remodelling occurring with cyclical
ovarian hormone stimulation. However, rapid expansion of the
epithelium again occurs during pregnancy and lactation, when adult
MaSCs proliferate to form lobuloalveolar structures capable of
producing and expelling milk for neonatal nourishment (Davis
et al., 2016; Lloyd-Lewis et al., 2017; Sreekumar et al., 2015).
Despite their essential role in pre- and postnatal mammary gland
development, studies to determine the molecular identity and
differentiation potential of MaSCs have yielded conflicting results
(for recent reviews, see Sreekumar et al., 2015; Lloyd-Lewis et al.,
2017). Recently, both saturation and single-cell genetic lineage-
tracing studies have demonstrated that lineage-restricted MaSCs
appear to drive postnatal mammary development under
physiological conditions (Davis et al., 2016; Scheele et al., 2017;
Wuidart et al., 2016). However, these studies also demonstrated
significant redundancy and heterogeneity within the adult MaSC
compartment, and the differential and stage-specific contribution of
diverse stem/progenitor cells in the breast is still emerging (Bach
et al., 2017; Cai et al., 2017; Van Keymeulen et al., 2017; Wang
et al., 2017). In this study, we employed a low-density, neutral,
genetic labelling strategy to further investigate the extent and nature
of the contribution of proliferative stem/progenitor cells to
embryonic, pubertal and reproductive mammary development.
RESULTS AND DISCUSSION
A pool of lineage-biased adult stem/progenitor cells propel
ductal elongation during puberty
Recently, genetic lineage-tracing studies in the mouse mammary
gland have achieved in vivo indelible marking of specific
populations of cells (characterised by their expression of
nominated genes at specific developmental stages) and theReceived 3 February 2018; Accepted 19 June 2018
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subsequent analysis of the progeny of proliferative labelled cells
after an appropriate chase (Sale and Pavelic, 2015). Targeted cell
populations include those temporally or stably expressing: keratin
(K) 5 (Rios et al., 2014; Van Keymeulen et al., 2011), K14 (Rios
et al., 2014; Tao et al., 2014; Van Keymeulen et al., 2011; Wuidart
et al., 2016), K8 (Tao et al., 2014; Van Keymeulen et al., 2011;
Wuidart et al., 2016), K18 (Van Keymeulen et al., 2011), K19
(Wuidart et al., 2016), Elf5 (Rios et al., 2014), Lgr5 (de Visser et al.,
2012; Fu et al., 2017; Rios et al., 2014; Van Keymeulen et al., 2011;
Wuidart et al., 2016), Lgr6 (Blaas et al., 2016; Wuidart et al., 2016),
Sox9 (Wang et al., 2017; Wuidart et al., 2016), Axin2 (van
Amerongen et al., 2012), Notch1 (Rodilla et al., 2015), Notch2
(Šale et al., 2013), Notch3 (Lafkas et al., 2013), WAP (Chang et al.,
2014), Acta2 (Prater et al., 2014), p63 (Sreekumar et al., 2017),
Procr (Wang et al., 2015), prominin 1 (Wang et al., 2017) and ER
(Van Keymeulen et al., 2017). However, although providing
valuable information on mammary development and the epithelial
differentiation hierarchy, these models have relied on prior
assumptions regarding the specificity and consistency of the
expression of the chosen gene promoters, and have generated
conflicting results.
In this study, we have employed a neutral genetic labelling
strategy for lineage analysis in the mammary gland using
R26CreERT2;R26Confetti mice (Fig. 1A) (Davis et al., 2016; Li et al.,
2016; Scheele et al., 2017). Administration of a low dose of
tamoxifen induces the stochastic expression of up to four
fluorescent proteins (FPs) (Fig. 1A). Importantly, FP expression
can occur in any cell, overcoming issues pertaining to the requisite
high-level Cre specificity inherent to other models (discussed by
Wuidart et al., 2016; Davis et al., 2016 ; Lloyd-Lewis et al., 2017).
Fig. 1. Lineage tracing during branching
morphogenesis. (A) The R26CreERT2;R26Confetti
model. R26CreERT2 mice (expressing inducible
Cre-recombinase in all cells) were crossed to
R26Confetti mice (expressing a conditional
multicolour reporter in all cells) to generate double
hemizygous mice. Administration of low-dose
tamoxifen produced stochastic genetic labelling of
cells at relatively low density. Labelling outcomes
include membranous CFP (mCFP), nuclear GFP
(nGFP), cytosolic YFP (YFP) or cytosolic RFP
(RFP); however, CFP+ clones (Fig. S2) were
under-represented (Davis et al., 2016) and were
not analysed. (B) For lineage tracing during
branching morphogenesis, tamoxifen was
administered (4 weeks) and tissue harvested
(7 weeks). (C,D) Example of single-colour
branches (C) and multicoloured branches (D).
Images show maximum-intensity z-projections
and optical slices of a region of interest (boxed
and enlarged in the right-hand panels). (E) The
percentage of single- and multicolour branches in
pubertal mice. (F) Cell neighbour analysis
revealed that the majority of FP+ cells had a same-
colour FP+ neighbour that was the same lineage.
Box extends from the 25th to 75th percentiles and
whiskers indicate minimum to maximum values.
Data are from 1419 cells distributed across 130
branches from randomly selected 3D images
(five mice).
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Neutral labelling of proliferative cells at clonal density (where the
chance of clone convergence is extremely low) has previously been
described using the R26CreERT2;R26Confetti model (using an ‘ultra-
low’ dose of tamoxifen; 0.2 mg per 25 g body weight) (Scheele
et al., 2017) and the R26[CA]30 model (Davis et al., 2016). Using
these models combined with 3D imaging, all of the progeny of a
single labelled cell can be analysed with confidence. These studies
revealed that lineage-restricted stem/progenitor cells orchestrate
ductal (Davis et al., 2016; Scheele et al., 2017) and alveolar (Davis
et al., 2016) mammary morphogenesis. However, they also revealed
extraordinary multiplicity in the MaSC compartment and thus their
power to capture the full spectrum of mammary stem/progenitor
cells is limited.
In the current study, we injected pubertal R26CreERT2;R26Confetti
mice with 0.5 mg tamoxifen (∼35 µg/g) to achieve low-density
labelling in the mammary epithelium (Fig. 1B and Fig. S1A). This
dose is approximately fourfold higher than previous studies using
‘ultra-low’ tamoxifen dosing in puberty (Scheele et al., 2017).
Using this approach, we observed mammary branches that
contained labelled cells of a single colour (Fig. 1C) as well as
branches comprising two or more colours (Fig. 1D), as expected. No
labelling was observed in control vehicle-injected mice (Fig. S1B).
Quantification of the number of single- and multicoloured branches
indicated that, under these conditions, the likelihood of clone
convergence is at least 50% (Fig. 1E); this number may be even
higher, as distinct coincident labelling events of the same colour
cannot be distinguished.
Consistent with previous reports (Davis et al., 2016), we observed
stochastic dispersion of labelled cell progeny throughout the
developing ducts (Fig. 1C,D and Fig. S3). This labelling pattern
is likely to have arisen from the deposition of labelled progeny along
developing ducts by proliferative labelled cells in elongating TEBs
(Bai and Rohrschneider, 2010; Davis et al., 2016). As ductal
elongation and side branching occur as the result of cell proliferation
by stem/progenitor cells within both TEB and ductal structures and
the admixing of clonal progeny (Fu et al., 2017; Rios et al., 2014;
Wang et al., 2015), we employed a cell-neighbour analysis to assess
lineage potential (Fig. 1F; see supplementary Materials and
Methods). A striking majority of same-colour cell neighbours
consisted of cells of the same lineage, providing further evidence of
physiological lineage bias in the postnatal mammary gland (Davis
et al., 2016; Scheele et al., 2017; Van Keymeulen et al., 2011; Wang
et al., 2017; Wuidart et al., 2016).
Alveolar morphogenesis is driven by a pool of lineage-biased
adult stem/progenitor cells
Low-density labelling using the R26CreERT2;R26Confetti model was
also used for lineage analysis during alveolar morphogenesis
(Fig. 2, Figs S4 and S5). R26CreERT2;R26Confetti mice were
injected with low-dose tamoxifen (1 mg per mouse; ∼40-50 µg/g)
(Fig. S5A), mated and tissue harvested during lactation (Fig. 2A).
Under these conditions, a large number of single-colour alveoli
were observed (Fig. 2B,C and Fig. S4) with fewer multicoloured
alveoli (Fig. 2D). No FP+ cells were observed in control mice
(Fig. S5B). Analysis of individual alveolar units revealed the vast
majority (96.6%) of alveoli were single-coloured (Fig. 2E). Of the
single-coloured alveoli, only 0.1% contained both luminal and basal
cells of the same colour (Fig. 2F). Thus, these data support previous
lineage-tracing studies using a different neutral model at single cell
density showing lineage restriction during alveolar morphogenesis
(Davis et al., 2016). Previous single cell lineage-tracing studies,
which quantified only very large labelled clones (containing
hundreds of labelled cells, with each clone presumably arising
from a single MaSC), demonstrated that most alveoli comprise the
progeny of a pool of lineage-restricted cells (Davis et al., 2016).
Analysis of the number of partially versus fully populated alveoli in
this low-density model revealed a seemingly higher rate of
polyclonality (Fig. 2G). This is likely due to the inclusion of
small, medium and large clones in the current study, representing
the wider spectrum of stem and progenitor cell divisions.
Neutral lineage tracing supports the presence of
lineage-biased embryonic stem/progenitor cells by
late embryogenesis
Although MaSCs appear to be lineage restricted postnatally,
numerous studies have suggested that their foetal precursors are
multipotent (Boras-Granic et al., 2014; Fu et al., 2017; Rodilla et al.,
2015; Spike et al., 2012; Trejo et al., 2017; Van Keymeulen et al.,
2011; Wang et al., 2015). Embryonic MaSCs display multipotential
activity in in vitro and transplantation assays, and increase
dramatically in number during this developmental window (Spike
et al., 2012). Moreover, in vivo population-based fate mapping has
shown that all mammary epithelial lineages derive from embryonic
K14-expressing stem/progenitor cells labelled at E17 (Van
Keymeulen et al., 2011), an observation reinforced by other
lineage-tracing studies using different gene promoters (Fu et al.,
2017; Rodilla et al., 2015; Trejo et al., 2017; Wang et al., 2015).
However, whether embryonic MaSCs are truly multipotent or
whether they consist of populations of distinct progenitors that are
already committed to give rise to different lineages after birth, has
remained subject to deliberation. In addition, it has remained
unclear when putative multipotent embryonic MaSCs become
lineage restricted. Recent studies using low-density lineage tracing
of embryonic cells have shed new light on this debate (Lilja et al.,
2018; Wuidart et al., 2018). Clonal labelling of K14-expressing
cells at E13 (when K14 appears to be universally expressed in
luminal and basal lineages) points to the existence of multipotent
stem cells at this stage of mammogenesis (Wuidart et al., 2018).
However, at birth, segregation of basal and luminal lineages appears
to be complete, with K5-expressing (Wuidart et al., 2018) and
Acta2-expressing (Lilja et al., 2018) cells exclusively giving rise to
basal progeny, and Notch1-expressing (Lilja et al., 2018) cells
exclusively giving rise to luminal progeny. As targeted promoters
may be differentially expressed in the neonatal and prenatal
mammary gland (Sun et al., 2010; Boras-Granic et al., 2014;
Trejo et al., 2017), definitive determination of the potential of
embryonic MaSCs and their perinatal lineage segregation requires a
neutral and inducible approach to labelling that is independent of
these promoters. In addition, it has been demonstrated (Rios et al.,
2016) that enzymatic digestion prior to 3D visualisation (Lilja et al.,
2018; Wuidart et al., 2018) can alter tissue architecture and cell
morphology, potentially confounding lineage-tracing outcomes.
Unequivocal lineage determination must therefore include studies
that employ methods of 3D visualisation that are void of proteolytic
digestion (Lloyd-Lewis et al., 2016). To address this, a single low-
dose of tamoxifen (33 µg per g maternal body weight) was
administered by oral gavage to pregnant transgenic mice to induce
incontrovertible neutral labelling in R26CreERT2;R26Confetti embryos
at E16.5-E17.5. This route of delivery, although subject to first-pass
metabolism, is reported to have less embryonic toxicity and more
uniform recombination by Cre (Park et al., 2008). Mammary glands
of offspring labelled in utero were subsequently visualised in 3D
(without prior proteolytic digestion) (Fig. 3A). Using this approach,
we observed large regions of labelled cells, some spanning from the
3
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nipple to the outer reaches of the fad pad (Fig. 3B-F, and Fig. S6).
3D imaging of areas proximal to the nipple revealed that these
regions always comprised cells of two or more colours (Fig. 3C).
Ductal branches in distal regions, however, more commonly
contained cells of a single colour (Fig. 3D-F versus Fig. S7).
Quantification of the number of single- and multicoloured branches
in nipple and distal regions confirmed this observation, and
indicated that the likelihood of clone convergence under these
conditions was high (Fig. 3G). Mixed-lineage cells of the same
colour were occasionally detected in both nipple (Fig. 3C) and distal
(Fig. 3F) ductal regions, supporting the notion that embryonic
MaSCs may possess multipotent capacity (Spike et al., 2012; Van
Keymeulen et al., 2011). However, a cell neighbour analysis
indicated that the majority of same-colour neighbours consisted of
cells of the same lineage (Fig. 3H), suggesting that embryonic stem/
progenitor cells are already lineage biased in the foetal mammary
gland. Indeed, a recent study, which was able to achieve multicolour
labelling at clonal density, has demonstrated that Notch1-expressing
cells display lineage restriction at E15.5 and E17.5 (Lilja et al.,
2018). It is important to note, however, that although the results of
this study at E16.5-E17.5 are consistent with previous analyses at
clonal density (Lilja et al., 2018; Wuidart et al., 2018), mammary
glands in our study are marked at levels higher than clonal density
and thus we cannot exclude the possibility that bipotent embryonic
MaSCs were initially labelled and gave rise to luminal and basal
progeny that expanded only after lineage specification occurred.
A single stem cell labelled in utero can contribute extensively
to both the basal and luminal lineages in the adult mammary
gland. Whereas the low-density and neutral R26CreERT2;R26Confetti
model provided important corroborating evidence into the fate of
primordial stem/progenitor cells to mammary development, we
sought to reinforce these observations using an alternative neutral
approach. To achieve this, we used the R26[CA]30 reporter mouse
model (Kozar et al., 2013) that was previously exploited to achieve
unbiased, single-cell labelling in the mammary gland (Davis et al.,
2016). This model encompasses a [CA]30 microsatellite repeat
positioned directly upstream of an out-of-frame modified
β-glucosidase (SYNbglA) reporter gene targeted to the Rosa26
locus (Fig. 4A). During DNA replication, spontaneous frame-shift
mutations in the inherently unstable dinucleotide repeat tract may
place the reporter gene in-frame, leading to its expression. This
‘strand slippage’ produces a permanent mark on the cell, which is
subsequently transmitted to all of its progeny. Importantly, genetic
labelling in this model is exceedingly rare, thereby allowing the
Fig. 2. Lineage tracing after alveolar
morphogenesis. (A) Tamoxifen was
administered (∼12 weeks), mice were
mated (∼14 weeks) and tissue
harvested during lactation.
(B-D) Example of single-colour luminal
YFP+ alveoli (B), single-colour luminal
YFP+ and RFP+ adjacent alveoli within
a larger lobuloalveolar structure
(arrowheads indicate different alveoli)
(C) and multicolour basal GFP+ and
YFP+ alveoli (D; red arrows show GFP+
and YFP+ cells within a single
alveolus). Images show maximum-
intensity z-projections and optical
slices of a region of interest (boxed and
enlarged in the right-hand panels).
(E) Graph (data are mean±s.e.m.)
showing the percentage of single- and
multicoloured alveoli; a lower rate of
clone convergence is observed in this
model following expansion during
gestation and lactation. (F) Graph
(data are mean±s.e.m.) showing the
percentage of FP+ alveoli in which the
same-colour cells were the same
lineage (i.e. all luminal or all basal) or
where same-colour cells were mixed
lineage (both luminal and basal).
(G) Fraction of alveoli that were fully
populated by single-colour FP+ cells
of a single lineage (full) versus those
populated by both single- or
multicoloured FP+ cells and/or
unlabelled cells of a single lineage
(partial). Data represent 1016 alveoli
from randomly selected 3D images
(three mice).
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fate of a single-labelled cell to be traced with a high degree
of confidence.
Using this model, we observed variable numbers of label-positive
cells randomly intermixed with unlabelled cells in developing ducts
(Fig. 4B), mirroring the stochastic labelling pattern observed in
pubertal R26CreERT2;R26Confetti mice (Fig. 1C,D). The majority of
labelled progeny arising from a single β-glucosidase+ cell expressed
markers of the luminal lineage (Fig. 4C), potentially reflecting the
higher proliferative capacity in this compartment compared to basal
cells (Giraddi et al., 2015). Isolated regions containing limited
numbers of label-positive cells were most-commonly observed
(Fig. 4B). These most likely arose from a recent frame-shift
mutation, or from strand slippage in replicative-restricted
progenitors or differentiated cells. Occasionally, large, contiguous
clonal regions spanning several ductal branches were also observed,
which were considered to have arisen from a single proliferative
MaSC/progenitor cell.
On one occasion, we observed ductal regions that comprised
exclusively β-glucosidase+ basal cells in close proximity to regions
comprising only β-glucosidase+ luminal cells (Fig. 4D,E). The
expansive size of this clone (>10 mm), in addition to its location at
the nipple region of the mammary gland, suggest that a bipotent
MaSC was labelled at some point during embryogenesis, giving rise
to a luminal and a basal daughter cell that later generated lineage-
Fig. 3. Lineage tracing following
embryonic labelling. (A) Tamoxifen
(33 µg/g maternal weight) was
administered by oral gavage (E16.5-
E17.5) and tissue harvested from
R26CreERT2;R26Confetti offspring.
(B) Analysis was divided into nipple
regions and distal branches. (C) Example
of a multicoloured nipple region. Arrow
and arrowhead indicate adjacent RFP+
basal and luminal cells, respectively.
(D) Example of single-colour distal
branches and terminal end buds (TEBs)
comprising YFP+ basal cells. i and ii are
two examples showing the same thing.
(E) Example of single-colour distal
branches and TEBs comprising RFP+
luminal cells. (F) Example of a rare distal
branch containing interspersed RFP+
luminal and basal cells. Images show
maximum-intensity z-projections and
optical slices of a region of interest (boxed
and enlarged in the right-hand panels).
Arrow and arrowhead in F show adjacent
RFP+ basal and luminal cells,
respectively. (G) Graphs (data are mean
±s.e.m.) showing the percentage of
single- and multicoloured nipple regions
and distal branches. (H) Cell neighbour
analysis showing that the majority of FP+
cells had a same-colour FP+ neighbour of
the same lineage [data are mean±s.e.m.
of 940 cells (seven nipple regions, n=5
mice) and 4439 cells (85 distal branches,
n=7 mice) from randomly-selected 3D
images].
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restricted progeny during postnatal development. Remarkably, we
also observed a clone that spanned the entire abdominal mammary
gland (Fig. 4F). This is in stark contrast to the contribution of cells
labelled during late embryogenesis in R26CreERT2;R26Confetti mice,
which appeared, overall, more limited in scope (Fig. 3). The vast
nature of this exceptional clone (and its origin at the nipple region)
might, therefore, suggest that a cell was marked very early in
development, likely before E12.5-E13.5, where clone size was
considerably and consistently smaller (Lilja et al., 2018; van
Amerongen et al., 2012; Wuidart et al., 2018). However, without
knowing the precise stage of labelling in the R26[CA]30SYNbglA
model, the differential contribution of these putative embryonic
cells to ductal morphogenesis in this model (Fig. 4D versus 4F)
could also point to heterogeneity and multiplicity within the
embryonic MaSC compartment. Histochemical analysis of this rare
clone (Fig. 4F) revealed that the majority of labelled cells were
luminal (Fig. 4G), further suggesting that some MaSCs might
exhibit a degree of lineage bias, even during early embryonic
development.
The origin of luminal and basal cell lineages in the mammary
gland has been the subject of intense investigation and debate.
Recent saturation lineage-tracing, single-cell lineage-tracing and
promoter-driven lineage-tracing studies have provided support for
lineage restriction of MaSCs from late embryogenesis into
Fig. 4. Single-cell genetic labelling using the
R26[CA]30SYNbglA model. (A) Schematic
representation of the R26[CA]30 model.
(B,C) Dispersion of β-glucosidase+ cells (purple)
throughout the ductal epithelium (green) (B) and
lineage analysis of β-glucosidase+ cells with
immunohistochemistry (C). (D,E) Example of a
β-glucosidase+ clone that originated at the nipple
region (asterisk) (D) and consisted of regions
containing β-glucosidase+ luminal cells adjacent to
regions containing β-glucosidase+ basal cells (E).
Arrows and arrowheads show cells with a basal and
luminal morphology, respectively. (F) A rare clone
spanning the entire abdominal mammary gland.
Asterisk indicates the nipple region. (G) Lineage
analysis of β-glucosidase+ cells with
immunohistochemistry. Black arrows indicate β-
glucosidase+ basal cells among β-glucosidase+
luminal cells. Scale bars: 20 µm. Clones shown in D
and F represent two out of three putative embryonic
labelling events observed from the analysis of 30
mice.
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adulthood (Davis et al., 2016; Li et al., 2016; Lilja et al., 2018;
Van Keymeulen et al., 2011; Wuidart et al., 2016, 2018). However,
the lack of evidence for the presence of multilineage clones does not
unequivocally show that bi/multipotent stem cells do not exist (Rios
et al., 2016; Visvader and Stingl, 2014). Thus, it is imperative that
the epithelial hierarchy in the mammary gland is rigorously assessed
at various developmental stages, using a range of methods, models
and systems of analyses. Using a low-density, neutral, genetic
labelling strategy and method of imaging that is free of proteolytic
digestion, we have provided corroborating evidence of the lineage
restriction of proliferative stem/progenitor cells to the three major
stages of mammary development: in the late embryo, during puberty
and in reproduction. Our findings also confirm that remarkable
heterogeneity exists within the adult mammary stem and progenitor
cell compartment, and suggest similar multiplicity within their
embryonic precursors. Importantly, we have revealed the
remarkable capacity of a single embryonic MaSC to contribute to
ductal development, providing unprecedented insights that could
only be disclosed by this single-cell approach. It is increasingly
hypothesised that certain cancers may arise from reactivation of
embryonic developmental programs in postnatal tissues (Howard
and Veltmaat, 2013; Wahl and Spike, 2017). Thus, an elucidation of
the full spectrum of stem/progenitor cell populations in the pre- and
postnatal mammary gland is paramount for defining the cellular
origin of heterogeneous breast tumours.
MATERIALS AND METHODS
Antibodies and reagents
Antibodies used in these studies include: rabbit anti-SMA (Abcam,
ab5694, lot number GR248336-23, 1:200 and 1:300 for 2D and 3D
studies, respectively), rat anti-K8 (Developmental Studies Hybridoma
Bank, TROMA-I, 1:200 and 1:50 of supernatant for 2D and 3D studies,
respectively), rabbit anti-E-cadherin (Cell Signaling, 3195, lot number
10, 1:400), goat anti-rabbit AlexaFluor (AF) 647 (Thermo Fisher Scientific,
A21245, lot number 1805235, 1:500) and anti-rabbit horseradish
peroxidase (HRP) (DAKO, P0448, lot number 20023997, 1:500). See
supplementary Materials and Methods for further information and
Lloyd-Lewis et al. (2016) for optimisation and validation studies.
Animal models
All animal experimentation was carried out in accordance with the Animal
(Scientific Procedures) Act 1986, the European Union Directive 86/609,
and with local ethics committee approval. Mouse (Mus musculus) strains
R26[CA]30 (Kozar et al., 2013) (a kind gift from Prof. D. Winton, Cancer
Research UK Cambridge Institute), R26Confetti (Livet et al., 2007) and
R26CreERT2 (Ventura et al., 2007) have previously been described. R26[CA]30
experimental mice were hemi- or homozygous for R26[CA]30SYNbglA. Mice
were analysed for β-glucosidase expression during adulthood (7-22-weeks).
Multi-colour lineage-tracing studies were performed on mice that were
hemizygous for both R26Confetti and R26CreERT2 (R26Confetti;R26CreERT2
mice). See supplementary Materials and Methods for further information.
Induction of lineage tracing in R26Confetti;R26CreERT2 mice
Tamoxifenwas prepared in sunfloweroil containing 10%ethanol. For lineage
tracing during puberty in R26Confetti;R26CreERT2 mice, labelling was induced
at the onset of puberty (4weeks of age) by a single intraperitoneal injection of
tamoxifen (0.5 mg per mouse, ∼35 μg/g) and tissue was harvested from 7-
week-old mice. Using this dose, mammary gland development appeared to
progress unabated, as previously reported (Rios et al., 2014). For lineage-
tracing in lactating R26Confetti;R26CreERT2 mice, labelling was induced after
puberty (12-14 weeks old) by a single intraperitoneal injection of tamoxifen
(1 mg per mouse, ∼40-50 μg/g), which did not grossly affect alveolar
development, as previously reported (Rios et al., 2014). After 10 days, female
mice were mated with C57BL/6J male studs and lactating tissue was
harvested between lactation days 4 and 5. For embryonic labelling,
homozygous R26Confetti mice were mated with homozygous R26CreERT2
mice. A single dose of tamoxifen (33 μg per g maternal body weight)
containing progesterone (13 µg per g maternal body weight) was
administered to pregnant mice via oral gavage at E16.5-17.5 (Li et al.,
2016; Park et al., 2008). Using this dose, terminal end buds (TEBs) appeared
morphologically normal and branching morphogenesis appeared normal via
stereomicroscopy (Fig. S6). Mice were allowed to litter and tissue was
collected from R26Confetti;R26CreERT2 offspring 6 weeks after birth.
Optical tissue clearing and whole-mount immunostaining
Fixed mammary tissue was cut into large pieces (∼15×15×2 mm) for
immunostaining and tissue clearing, without any mechanical or enzymatic
manipulation or microdissection. Optical tissue clearing was performed
using either SeeDB (Ke et al., 2013) or a modified CUBIC (Reagent 1A)
protocol (Susaki and Ueda, 2016), as previously described in detail (Lloyd-
Lewis et al., 2016). Whole-mount immunostaining was performed prior
to tissue clearing (SeeDB) or following immersion in CUBIC Reagent 1A,
as previously described. See supplementary Materials and Methods for
further information.
Confocal microscopy
Optically clear tissues were imaged in their respective refractive index
matching solutions in 35 mm glass-bottom MatTek dishes. Images were
acquired using a Leica TCS SP8 inverted confocal microscope with 10×/0.4
or 20×/0.75 HC PL APO objective lenses. All colours (GFP, YFP, RFP and
far red) were imaged for consistency and quantification. CFP-expressing
clones were under-represented and were not routinely imaged (see Fig. S2).
See supplementary Materials and Methods for further information.
Whole-mount histochemistry
Detection of modified β-glucosidase expression in the mammary gland was
performed as previously described (Davis et al., 2016). Briefly, excised
mammary glands were fixed at room temperature for 4 h in NBF (10%).
Tissue was heated to 65°C for 15 min in phosphate-buffered saline for
endogenous β-glucosidase inactivation. Whole-mount mammary glands
were incubated for 24 h at 50°C in a solution containing one part solution A
[5-bromo-6-chloro-3-indolyl-β-D-glucopyranoside (1%) in dimethyl
sulfoxide] and 25 parts solution B [magnesium chloride (0.02% w/v),
potassium ferricyanide (0.096% w/v) and potassium ferrocyanide (0.13%
w/v) in PBS]. After 24 h, the substrate was replenished and tissue incubated
for an additional 24 h. Mammary glands were post-fixed in 10% NBF
overnight at 4°C. Tissue clearing was performed using the CUBIC clearing
protocol (Susaki et al., 2014), with methyl green counterstaining, as
previously described (Davis et al., 2016; Lloyd-Lewis et al., 2016).
Histology
For histological analysis of tissue from R26[CA]30SYNbglA mice, CUBIC-
based tissue clearing was reversed by overnight incubation in PBS at 4°C.
Paraffin processing was performed using a butanol clearing protocol, to
maintain the histochemical magenta staining. Briefly, tissue was placed in a
cassette and immersed in 70% ethanol (2 h), 96% ethanol (2 h), 100%
ethanol (2 h) and finally transferred to n-butanol for 2 h before paraffin wax
embedding. Paraffin wax-embedded sections (4-6 µm) were de-waxed in
xylene (3×2 min washes) and processed as described above. Primary
antibodies used for immunohistochemistry on paraffin slides were: rabbit
anti-SMA (Abcam, ab5694, 1:200) and rabbit anti-E-cadherin (Cell
Signaling, 3195, 1:50). Goat anti-rabbit HRP-conjugated secondary
antibody (Jackson ImmunoResearch) was used at a dilution of 1:250.
Clonal analysis method
A cell neighbour analysis was used to analyse labelling outcomes in this
study and is described in detail in the supplementaryMaterials andMethods.
Briefly, we created z-projections of randomly selected 3D image stacks
containing label-positive cells. For all cells within each region, the lineage
of the closest same-colour neighbour was recorded as either ‘same’ or
‘different’ by manual scoring. GFP, YFP, RFP and far red channels were
imaged for each image sequence.
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